Financial comparisons Northwest Biotherapeutics, Inc. Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart 23:56:07 30/09/2026 +04			5-day change	1st Jan Change
0.1310 ^EUR	0.00%		-18.12%	-36.41%

08-15	Northwest Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Northwest Biotherapeutics and Saudi Pharmaceutical Industries and Medical Appliance Company Enter Memorandum of Understanding for Collaboration	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (N-1)	Net Margin (N-1)	EBIT Margin (N-1)	ROE (N-1)	ROA (N-1)	Leverage (N-1)
WUXI APPTEC CO., LTD.	6.5B	42.13%	52.64%	28.56%	20.88%	-0.99x
ARGENX SE	4.25B	30.41%	24.81%	20.15%	17.36%	-3.18x
LONZA GROUP AG	8.24B	14.53%	21.7%	10.28%	4.9%	1.58x
IQVIA HOLDINGS INC.	16.31B	8.34%	13.38%	32.9%	4.79%	3.63x
BEONE MEDICINES AG	5.34B	5.37%	8.37%	29.84%	16.27%	-5.99x
CELLTRION, INC.	2.88B	24.74%	28.07%	5.94%	4.75%	1.77x
WUXI BIOLOGICS (CAYMAN) INC.	3.12B	22.53%	31.44%	11.9%	8.13%	-1.19x
INSMED INCORPORATED	606M	-210.54%	-205.59%	-249.28%	-	0.72x
BIONTECH SE	3.37B	-39.59%	-48.95%	-5.88%	-5.1%	6.99x
GENMAB A/S	3.69B	25.89%	28.63%	17.53%	9.99%	-1.51x
MEDPACE HOLDINGS, INC.	2.53B	17.83%	20.93%	70.23%	22.13%	-0.89x
PHARMAESSENTIA CORPORATION	498M	32.27%	31.52%	16.97%	14.74%	-3.83x
EUROFINS SCIENTIFIC SE	8.57B	6.51%	14.79%	9.61%	4.34%	2.22x
ASCENDIS PHARMA A/S	846M	-31.67%	-18.92%	-	-	1.57x
TEMPUS AI, INC.	1.27B	-19.27%	-3.71%	-38.64%	-6.61%	-65.61x
EXELIXIS, INC.	2.32B	33.73%	37.59%	35.53%	27.02%	-1.18x
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	294M	-18.56%	-24.05%	-9.34%	-9.05%	8.22x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.02B	-3.59%	19.77%	15.46%	6.99%	1.98x
Average	4.15B	-3.27%	1.8%	0.1%	8.85%	-3.09x
Weighted average by Cap.	5.28B	4.04%	8.51%	5.08%	10.63%	-1.86x